JPS52116479A - Novel derivative of 33quinolinecarboxylic acid and method for its preparation and phamaceutical composition thereof - Google Patents

Novel derivative of 33quinolinecarboxylic acid and method for its preparation and phamaceutical composition thereof

Info

Publication number
JPS52116479A
JPS52116479A JP1313977A JP1313977A JPS52116479A JP S52116479 A JPS52116479 A JP S52116479A JP 1313977 A JP1313977 A JP 1313977A JP 1313977 A JP1313977 A JP 1313977A JP S52116479 A JPS52116479 A JP S52116479A
Authority
JP
Japan
Prior art keywords
preparation
acid
novel derivative
phamaceutical composition
phamaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1313977A
Other languages
English (en)
Japanese (ja)
Other versions
JPS623152B2 (cg-RX-API-DMAC10.html
Inventor
Are Andore
Kuremansu Furansowa
Dorae Rojie
Ru Marutore Odeiru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of JPS52116479A publication Critical patent/JPS52116479A/ja
Publication of JPS623152B2 publication Critical patent/JPS623152B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02—Magnesium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
JP1313977A 1976-02-11 1977-02-10 Novel derivative of 33quinolinecarboxylic acid and method for its preparation and phamaceutical composition thereof Granted JPS52116479A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7603754A FR2340735A1 (fr) 1976-02-11 1976-02-11 Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Publications (2)

Publication Number Publication Date
JPS52116479A true JPS52116479A (en) 1977-09-29
JPS623152B2 JPS623152B2 (cg-RX-API-DMAC10.html) 1987-01-23

Family

ID=9168994

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1313977A Granted JPS52116479A (en) 1976-02-11 1977-02-10 Novel derivative of 33quinolinecarboxylic acid and method for its preparation and phamaceutical composition thereof

Country Status (19)

Country Link
US (1) US4107310A (cg-RX-API-DMAC10.html)
JP (1) JPS52116479A (cg-RX-API-DMAC10.html)
AU (1) AU508345B2 (cg-RX-API-DMAC10.html)
BE (1) BE851306A (cg-RX-API-DMAC10.html)
CA (1) CA1089464A (cg-RX-API-DMAC10.html)
CH (1) CH620437A5 (cg-RX-API-DMAC10.html)
DD (1) DD129552A5 (cg-RX-API-DMAC10.html)
DE (1) DE2705446A1 (cg-RX-API-DMAC10.html)
DK (1) DK150512C (cg-RX-API-DMAC10.html)
ES (1) ES455804A1 (cg-RX-API-DMAC10.html)
FR (1) FR2340735A1 (cg-RX-API-DMAC10.html)
GB (1) GB1572482A (cg-RX-API-DMAC10.html)
IE (1) IE44879B1 (cg-RX-API-DMAC10.html)
IL (1) IL51413A (cg-RX-API-DMAC10.html)
LU (1) LU76742A1 (cg-RX-API-DMAC10.html)
NL (1) NL7701398A (cg-RX-API-DMAC10.html)
SE (1) SE441528B (cg-RX-API-DMAC10.html)
SU (1) SU867299A3 (cg-RX-API-DMAC10.html)
ZA (1) ZA77787B (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5731665A (en) * 1980-05-19 1982-02-20 Roussel Uclaf 2-position substituted 4-hydroxy-3-quinoline carboxylic acid novel derivative, manufacture, use as drug and composition and novel intermediate containing same
JP2016506964A (ja) * 2013-01-31 2016-03-07 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ ナトリウムチャネルの調節剤としてのキノリンおよびキナゾリンアミド

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4190659A (en) * 1973-08-27 1980-02-26 Sandoz, Inc. Pharmaceutical preparation and use of 4-hydroxy-2-quinolinone-3-carboxylic acid esters
US4281131A (en) 1977-06-20 1981-07-28 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4187309A (en) * 1977-06-20 1980-02-05 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acids and salts thereof
US4273930A (en) * 1977-06-20 1981-06-16 Sandoz, Inc. 4-Hydroxy-2-quinolinone-3-carboxylic acid esters
US4221797A (en) * 1978-08-14 1980-09-09 Sandoz, Inc. Dihydroquinoline-one derivatives
FR2443467A1 (fr) * 1978-12-08 1980-07-04 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
US4266050A (en) * 1980-07-02 1981-05-05 American Home Products Corporation 1,2-Dihydro-4-hydroxy-2-imino-N-substituted-3-quinolinecarboxamide derivatives
IE52670B1 (en) * 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
HU190796B (en) * 1981-06-12 1986-11-28 Roussel Uclaf,Fr Process for producing n-dihydrothiazolyl-3-quinoline-carboxamide derivatives
FR2523130A1 (fr) * 1982-03-15 1983-09-16 Roussel Uclaf Nouveaux derives de la n-dihydrothiazolyl-3-quinoleine carboxamide, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2507602A1 (fr) * 1981-06-12 1982-12-17 Roussel Uclaf Nouveau derive dihydrothiazole de la quinoleine, ses sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2509728A1 (fr) * 1981-07-17 1983-01-21 Roussel Uclaf Nouveaux derives de la quinoleine, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant
FR2537139B2 (fr) * 1982-03-15 1985-09-20 Roussel Uclaf Nouveau derive de la n-dihydrothiazolyl 3-quinoleine carboxamide, procede de preparation, application a titre de medicament et compositions le renfermant
FR2551437B2 (fr) * 1982-06-03 1985-10-25 Roussel Uclaf Nouveaux derives de l'acide 4-oh 3-quinoleine carboxylique substitues en 2, nouveau procede de preparation, leur application comme medicament et les compositions les renfermant et produits necessaires a leur preparation
FR2530633A1 (fr) * 1982-06-03 1984-01-27 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant
FR2532939A1 (fr) * 1982-09-13 1984-03-16 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, les compositions les renfermant et les nouveaux intermediaires obtenus
FR2537140B1 (fr) * 1982-12-07 1986-07-18 Roussel Uclaf Nouveaux derives de la 4-hydroxy-3-quinoleine carboxamide, leur sels, procede de preparation, application a titre de medicaments, et compositions les renfermant
SE452170B (sv) * 1983-10-03 1987-11-16 Boliden Ab Forfarande for utvinning av metall ur koppar och/eller edelmetall innehallande material som innehaller antimon och vismut
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
US4602014A (en) * 1984-07-09 1986-07-22 Ciba-Geigy Corporation Ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives as benzodiazepine receptor modulators
JPH0358559A (ja) * 1989-07-26 1991-03-13 Sekisui Chem Co Ltd 電話システム
US5175151A (en) * 1990-09-07 1992-12-29 Schering Corporation Antiviral compounds and antihypertensive compounds
DE69128481T2 (de) * 1990-09-07 1998-04-09 Schering Corp Antivirale und antihypertensive verbindungen
US5179093A (en) * 1991-05-10 1993-01-12 Schering Corporation Quinoline-diones
DE4138820A1 (de) * 1991-11-26 1993-05-27 Basf Ag Chinolin-3-carbonsaeureamide, deren herstellung und verwendung
SE9201076L (sv) * 1992-04-06 1993-10-07 Shimon Slavin Användningen av gamla läkemedel för behandling av diabetes
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
TWI328009B (en) * 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
SE0400235D0 (sv) * 2004-02-06 2004-02-06 Active Biotech Ab New composition containing quinoline compounds
US8314124B2 (en) 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
CN104788328B (zh) 2004-06-24 2017-09-12 沃泰克斯药物股份有限公司 Atp‑结合弹夹转运蛋白的调控剂
RU2556984C2 (ru) * 2004-06-24 2015-07-20 Вертекс Фармасьютикалз Инкорпорейтед Модуляторы транспортеров атф-связывающей кассеты
WO2006087830A1 (ja) * 2005-02-18 2006-08-24 Kanebo, Ltd. 帯状織物構造体およびその製法
PT1937642E (pt) * 2005-10-19 2014-11-25 Teva Pharma Cristais de sódio de laquinimod, e processos para o fabrico dos mesmos
EP1979367A2 (en) * 2005-12-24 2008-10-15 Vertex Pharmaceuticals Incorporated Quinolin-4-one derivatives as modulators of abc transporters
WO2007079139A2 (en) 2005-12-28 2007-07-12 Vertex Pharmaceuticals, Inc. Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
KR20140091778A (ko) * 2006-06-12 2014-07-22 테바 파마슈티컬 인더스트리즈 리미티드 안정한 라퀴니모드 제제
WO2008097976A1 (en) * 2007-02-09 2008-08-14 Kalypsys, Inc. Heterocyclic modulators of tgr5 for treatment of disease
PL2234485T3 (pl) 2007-12-20 2014-06-30 Teva Pharma Stabilne preparaty lakwinimodu
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
KR20110048571A (ko) * 2008-09-03 2011-05-11 테바 파마슈티컬 인더스트리즈 리미티드 면역 기능을 지닌 ２―옥소―１,２―다이하이드로―퀴놀린 조절제
SG10201504084QA (en) 2009-03-20 2015-06-29 Vertex Pharma Process for making modulators of cystic fibrosis transmembrane conductance regulator
KR20160148050A (ko) * 2009-07-30 2016-12-23 테바 파마슈티컬 인더스트리즈 리미티드 라퀴니모드를 이용한 크론병의 치료
US9585878B2 (en) * 2009-08-10 2017-03-07 Teva Pharmaceutical Industries, Ltd. Treatment of BDNF-related disorders using laquinimod
KR20160129093A (ko) * 2010-03-03 2016-11-08 테바 파마슈티컬 인더스트리즈 리미티드 라퀴니모드를 이용한 루푸스 신장염의 치료
PH12012501741A1 (en) * 2010-03-03 2012-11-12 Teva Pharma Treatment of lupus arthritis using laquinimod
PH12012501740A1 (en) * 2010-03-03 2012-11-12 Teva Pharma Treatment of rheumatoid arthritis with a combination of laquinimod and methotrexate
CN102267984B (zh) * 2010-06-04 2014-07-30 中国人民解放军军事医学科学院毒物药物研究所 4-羟基喹啉-3-酰胺衍生物及其制备方法和用途
WO2012050500A1 (en) 2010-10-14 2012-04-19 Lars Pettersson 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators.
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP2537517A1 (en) * 2011-06-22 2012-12-26 Active Biotech AB Deuterium-enriched 4-hydroxy-5-methoxy-n,1-dimethyl-2-oxo-n-[(4-trifluoro-methyl)phenyl]-1,2-dihydroquinoline-3-carboxamide
WO2013055907A1 (en) 2011-10-12 2013-04-18 Teva Pharmaceutical Industries Ltd. Treatment of multiple sclerosis with combination of laquinimod and fingolimod
CN104093310A (zh) 2012-02-03 2014-10-08 泰华制药工业有限公司 拉喹莫德用于治疗一线抗TNFα疗法失败的克罗恩氏病患者的用途
CN109966264A (zh) 2012-02-27 2019-07-05 沃泰克斯药物股份有限公司 药物组合物及其施用
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
US8975279B2 (en) 2012-11-07 2015-03-10 Teva Pharmaceutical Industries, Ltd. Amine salts of laquinimod
WO2014153145A2 (en) 2013-03-14 2014-09-25 Teva Pharmaceutical Industries Ltd. Crystals of laquinimod sodium and improved process for the manufacture thereof
HK1231413A1 (zh) 2014-04-29 2017-12-22 Teva Pharmaceutical Industries Ltd. 用於治疗具有高残疾状况的复发-缓解型多发性硬化症(rrms)的患者的拉喹莫德
US9701639B2 (en) 2014-10-07 2017-07-11 Vertex Pharmaceuticals Incorporated Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE635597A (cg-RX-API-DMAC10.html) * 1962-03-01
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
FR2281761A1 (fr) * 1974-08-13 1976-03-12 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5731665A (en) * 1980-05-19 1982-02-20 Roussel Uclaf 2-position substituted 4-hydroxy-3-quinoline carboxylic acid novel derivative, manufacture, use as drug and composition and novel intermediate containing same
JP2016506964A (ja) * 2013-01-31 2016-03-07 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ ナトリウムチャネルの調節剤としてのキノリンおよびキナゾリンアミド

Also Published As

Publication number Publication date
IL51413A (en) 1980-09-16
ZA77787B (en) 1978-03-29
SU867299A3 (ru) 1981-09-23
NL7701398A (nl) 1977-08-15
LU76742A1 (cg-RX-API-DMAC10.html) 1977-08-19
DK56077A (da) 1977-08-12
DK150512C (da) 1987-11-16
DD129552A5 (de) 1978-01-25
DE2705446A1 (de) 1977-08-18
FR2340735B1 (cg-RX-API-DMAC10.html) 1978-11-03
ES455804A1 (es) 1978-01-16
CH620437A5 (cg-RX-API-DMAC10.html) 1980-11-28
DE2705446C2 (cg-RX-API-DMAC10.html) 1989-10-12
IL51413A0 (en) 1977-04-29
AU2221877A (en) 1978-08-17
FR2340735A1 (fr) 1977-09-09
AU508345B2 (en) 1980-03-20
CA1089464A (fr) 1980-11-11
GB1572482A (en) 1980-07-30
US4107310A (en) 1978-08-15
IE44879B1 (en) 1982-05-05
JPS623152B2 (cg-RX-API-DMAC10.html) 1987-01-23
DK150512B (da) 1987-03-16
SE441528B (sv) 1985-10-14
BE851306A (fr) 1977-08-10
IE44879L (en) 1977-08-11
SE7700804L (sv) 1977-08-12

Similar Documents

Publication Publication Date Title
JPS52116479A (en) Novel derivative of 33quinolinecarboxylic acid and method for its preparation and phamaceutical composition thereof
JPS568392A (en) Novel alkyloxime derivative of 77aminothiazolylacetamidocephalosporanic acid* its manufacture and medicinal composition
JPS5436296A (en) Nnsubstituted ester of 9*100dihydrolysergic acid and method for its preparation
IL52023A (en) Process for the preparation of di-n-propyl-acetic acid and salts thereof
SG9484G (en) Unsaturated-thio-derivatives of 7-acetamido-3-cephem-4-carboxylic acid and process for their preparation
PT66637B (en) Process for the preparation of 4-trifluoromethylbenzoic acid derivatives and pharmaceutical compositions containing same
JPS5318526A (en) Phenoxyyalkanone acid derivatives*process for preparation thereof and composition containing same
JPS52133989A (en) Novel aminopiperidines and method of their preparation and medical composition thereof
GB2039736B (en) Pharmaceutical compositions containing thiazolidine-4-carboxylic acid and method of preparation
PH13924A (en) Glavulanic acid derivatives,pharmaceutical compositions containing same and method of preparation thereof
NZ184408A (en) 16-s-acyl derivatives of 16-deacetoxy-fusidic acid and pharmaceutical compositions
JPS52122377A (en) Method of preparation of 22chloronicotinic acid
JPS51146476A (en) New preparation method of quinolinee33carbonic acid
PT68946A (en) Process for the preparation of salicylic acid and derivatives thereof
GB1554310A (en) Process for the preparation of 5-oxo-hexanoic acid and derivatives thereof
PH13873A (en) Substituted thenoylacetic acid and esters,their pharmaceutical composition and method of use
JPS5373535A (en) Phthalic acid derivative * method of its preparation and hardening mixture containing said compound
CH614191A5 (en) Process for the preparation of novel dioxamic acid derivatives and compounds thus prepared
JPS53121740A (en) 22*2* * 2* * 2**trihaloethyl**44haloo cyclobutanee11on * its method of production * intermediate for said production and use for production of derivative of cyclopropanecarboylic acid
JPS565450A (en) Manufacture of 3*33dimethyllcyclopropanee 1*1*22tricarboxylic acid derivative* novel intermediate alphaahalogennnitrile for said manufacture and its manufacture
JPS5219683A (en) Pseudooisocytidine and acid additive and preparation method thereof and useful intermediates for manufacture
GR64425B (en) Derivatives of 3-carboxyphenylesacetic acid and method for the preparation thereof
JPS5233619A (en) Method of direct preparation of nnacyl derivatives of alphaaaminoo gammaaketo acid and its new compound
JPS51113847A (en) Prostanic acid derivative and process for manufacture thereof and composition containing it
JPS5557591A (en) Cluvalanic acid derivative*its manufacture and composition